Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SQIN is a specialized dermatological product, often categorized as a medical device or a high-grade dermo-cosmetic, designed for the intensive care and protection of the skin barrier. It is primarily utilized in clinical and professional settings to manage severely dry, compromised, or sensitive skin conditions. The formulation typically focuses on replenishing essential skin lipids and providing a non-occlusive protective layer that facilitates natural healing processes. While it is marketed under the brand name SQIN, it is often recognized for its high concentration of biocompatible ingredients that mimic the skin's natural sebum and intercellular matrix, making it suitable for post-procedural care or chronic inflammatory skin conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SQIN.